Parenteral nutrition is a lifesaving procedure in patients who have intestinal failure defined as inadequate intestinal function for absorption of nutrients and electrolytes.
1 While in hospital, the patients who can be maintained on parenteral nutrition are educated in the aseptic infusion of nutrients and electrolytes, thereby avoiding the metabolic disturbances and malnutrition seen as a consequence of intestinal failure. When qualified in this complex procedure, the patients are discharged for home parenteral nutrition (HPN). Intestinal transplantation on the other hand is the ultimate lifesaving option when complications impede parenteral support, such as progressive liver failure, serial septic episodes, and venous inaccessibility, most frequently seen in the paediatric population. 2 3 Moving the parenteral support from the hospital to the home results in a significant gain in quality of life, 4 and as intestinal adaptation occurs, some patients may even be weaned oV parenteral supplements. Others, however, experience irreversible intestinal failure and face life-long complex technological nutritional support, which inevitably has an impact on their quality of life. HPN is a time consuming intrusive procedure, and HPN patients with intestinal failure are often troubled by the inconvenience of high intestinal output, presence of a stoma, fear of incontinence, altered body image, etc. These factors may impose severe restrictions on daily life with regard to social and leisure activities and emotional function, and the presence of malnutrition and dehydration in spite of HPN therapy may affect physical activity. In these patients the quality control of medical care must be focused towards proper control of the symptoms and complications of intestinal failure and treatment with HPN, aimed at full rehabilitation of the HPN patient.
As the results of intestinal transplantation will probably improve in the coming years, this procedure may become an alternative to HPN on the lines of renal transplantation versus dialysis, not only on vital indications, but also with the aim of improving quality of life in these patients.
In order to understand the experience of chronic illness and to describe behavioural dysfunction and problems related to HPN treatment, comparisons were made, using validated quality of life measurement techniques, between a population of patients receiving HPN monitored at the intestinal failure unit in Copenhagen in July 1997 and a group of non-HPN patients with known severe malabsorption, who managed without parenteral supplements.
Materials and methods

QUESTIONNAIRES
The study was based on two validated quality of life questionnaires: the sickness impact profile (SIP) 5 and the inflammatory bowel disease questionnaire (IBDQ). 6 The SIP is a non-disease specific behaviour based measure of sickness related dysfunction designed to cover patient perception of performance in areas of activity in everyday life. It contains 136 items in two main dimensions (physical (ambulation and mobility, body care and movement) and psychosocial (social interaction, alertness and emotional behaviour, communication)) and five independent categories (sleep and rest, eating, work, house keeping, recreation and pastimes). It is designed to be broadly applicable across types and severities of illness and across demographic and cultural subgroups. It has been used to collect and evaluate sickness related behavioural dysfunction in various diseases 7 8 and was chosen for this study to provide a measure of the non-disease specific function of the two groups of patients. Patients were asked to endorse or check those statements that accorded with their present situation. No positive answers was equivalent to no behavioural dysfunction. The SIP percentage scores of the dimensions and categories were obtained by summing the number of positive statements to the items in each dimension and category, dividing that sum by the total sum of the possible values, and multiplying the quotient by 100. Zero per cent indicates the best possible function (absence of dysfunction), whereas 100% indicates presence of all possible dysfunctional behaviour.
At the end of the SIP questionnaire, patients were asked to mark their overall quality of life on a 9 cm visual analogue scale. At the left at 0 cm a miserable quality of life was indicated, whereas an ideal quality of life was indicated at 9 cm at the right end of the scale.
The IBDQ was developed to measure subjective health status for patients with inflammatory bowel disease. The 32 item questionnaire examines four aspects of patients' lives: symptoms directly related to the primary bowel disturbance (10 questions), systemic symptoms (five questions), emotional (12 questions), and social function (five questions). This questionnaire is disease specific and was chosen to focus on bowel related symptoms and their impact on quality of life. The response options for each question were framed as a seven point scale on which 7 represented best function and 1 represented worst function. The score of each aspect has been given as a median on the seven point scale.
EXPERIMENTAL DESIGN AND PATIENTS
In June 1997 the two questionnaires were mailed to the total cohort of 57 patients (corresponding to 75% of patients receiving HPN in Denmark) followed at the intestinal failure unit in Copenhagen receiving HPN because of intestinal failure secondary to benign disease, and to 45 non-HPN patients, who had an anatomical and/or functional short bowel defined as <200 cm of remnant small bowel (26 patients) or a daily faecal energy loss measured by bomb calorimetry exceeding 2.0 MJ/day (∼488 kcal/day) during their last admission (37 patients). Written reminders were sent to non-responders after two months and the study was closed for inclusion at three months.
The population of patients receiving HPN in Denmark and the standardised care of these patients has been described in a recent study. 9 None of the patients had a history of an underlying psychiatric disorder. In only one HPN patient was the impairment of quality of life evidently secondary to the underlying disease and not necessarily related directly to HPN therapy. This patient suVered from CharcotMarie-Tooth syndrome, had intestinal dysmotility, and was partly immobilised as a result of the disease.
The HPN patients and their relatives were trained by a special team. An instruction manual was handed out, and the patients were discharged from hospital when they were able to carry out the procedures. Thus the HPN consumers were taught to be totally independent of nursing involvement with routine infusion. Home care companies delivered the HPN products, and even supplied them if the patients were away from their home town. Single-lumen catheters, inserted through the subclavian, jugular, or femoral vein and advanced to the vena caval-right atrial junction, were used. Administration was generally at night, but six patients with large stomal volumes had additional infusions of saline during the day. The recommended infusion time of standard 3 litre HPN bags was 10 hours. Infusion was by gravity in all patients.
The patients had 24 hour access to the intestinal failure unit in Copenhagen for emergencies. Nursing support at home was instituted for seven patients. All patients in this study were monitored in our outpatient clinic at intervals of about 6-12 weeks. During these visits patients were clinically assessed, weighed, and routine blood tests taken. At intervals of about one year, intestinal function was assessed using balance techniques that measured diet and faecal weight and energy content by bomb calorimetry. In the HPN patients the parenteral energy and electrolyte supplements were adjusted on a clinical basis to maintain normal body weight, hydration, diuresis, and levels of plasma albumin and electrolytes. This information was obtained from medical records, and remnant intestinal length was obtained from surgical records. The length of the colon was expressed in terms of percentage of the usual length by the method of Cummings et al. 10 Basal energy expenditure was calculated by Harris-Benedict equations using actual body weights. 
STATISTICAL ANALYSIS
A non-parametric Mann-Whitney rank sum test was used for the comparison of patient characteristics of the two study groups, the scores on the visual analogue scale in the SIP questionnaires, and the medians between groups in the IBDQ questionnaires. The 2 or Fisher exact test was used for comparison of the frequencies of confirmatory answers in the SIP questionnaire. The statistical software used was SigmaStat for Windows Version 2.0 (copyright 1992-1995; Jandel Corporation, Erkrath, Germany). p<0.05 was considered to indicate statistical significance.
Results
PATIENT DEMOGRAPHICS
Forty nine (86%) of the HPN patients and 36 (80%) of the non-HPN patients returned completed questionnaires; table 1 gives the demographics of these patients. The median duration of HPN treatment was 5.0 (range 0.2-27.8) years. The HPN patients were given a median of 2.23 (range 0.2-5.5) litres of parenteral fluid per day and 3.97 (range 0.0-10.5) MJ/day (∼948 (range 0-2508) kcal/ day) corresponding to a median of 73% of their basal energy expenditure. The HPN was infused for a median of seven (range four to seven) nights on a cyclic nocturnal basis, but six patients had saline supplements during daytime. The two groups did not diVer significantly with regard to sex ratio or age. Significantly more of the patients receiving HPN had a dysmotility disorder. Body mass index was lower in the HPN patients because of a lower body weight compared with the non-HPN patients. The remnant small bowel was significantly shorter and the presence of a stoma more predominant in the HPN patients compared with the non-HPN patients. In spite of a lower dietary energy intake, the HPN patients had a higher faecal weight than the non-HPN patients. The energy absorption in relation to the basal energy expenditure was 72% and 127% in the two groups respectively (p<0.001). Figure 1 gives a comparison of the overall SIP scores, dimensions, and categories between the HPN and non-HPN patients. A score of 0% indicates the best possible function (absence of dysfunction), whereas 100% indicates presence of all possible dysfunctional behaviour. The patients receiving HPN scored worse (higher scores) in all areas of activity. All 136 questions were individually compared in order to identify diVerences among the HPN and the non-HPN patients.
SIP SCORES
Physical dimension
The responses to questions on ambulation and mobility showed that the HPN patients used public transport less frequently (41%) than the non-HPN patients (11%) (p = 0.006). The HPN patients reported that they spent more 
SIP
time at home than the non-HPN patients (43% v 19%, p = 0.04), and social events and visits were shorter (35% v 8%, p = 0.01). In response to questions on body care and movement, 17% of the HPN patients reported needing help for diYcult movements-for example, getting into a car and getting out of the bath-compared with 0% in the non-HPN group (p = 0.04), and the HPN patients had more diYculty in maintaining their balance (14% v 0%, p = 0.04).
Psychosocial dimension
The HPN patients experienced a large impact on their psychosocial activities. As mentioned above, their social interaction was aVected because of problems with mobility. The responses to questions on social interaction showed that the HPN patients less frequently paid social visits to others (49% v 17%, p = 0.004), participated less in social arrangements (41% v 17%, p = 0.03), and were more often alone (29% v 5%, p = 0.02) than the non-HPN patients. Concerning alertness and emotional behaviour, the HPN patients in general scored worse (higher score) on questions about emotional stability and self confidence. Some 18% of the HPN patients felt that they were a nuisance to others compared with 3% of the non-HPN patients (p = 0.04). However, when asked about their prospects, the answers from the HPN patients were not more futile than those from the non-HPN patients. Some 43% of the HPN patients reported to have reduced sexual activity, but this did not diVer from the non-HPN patients (42%, p = 0.91). No significant diVerences for individual questions on communication were found between the two groups.
Independent categories
The HPN patients in general had greater sickness related dysfunction with regard to sleep and rest, but none of the diVerences in the answers to individual questions between the two groups reached statistical significance. For the questions on eating, 41% of the HPN patients reported having a reduced appetite compared with only 6% of the non-HPN patients (p<0.001). Only 14% of the HPN patients were in full time work compared with 44% of the non-HPN patients (p = 0.004). In questions about home management, 59% of the HPN patients reported carrying out less of the housework compared with 33% of the non-HPN patients (p = 0.03) and significantly less did the shopping (84% v 100%, p = 0.02), cleaning (76% v 94%, p = 0.04), and heavy, demanding work at home (47% v 86%, p<0.001). In questions on recreation and pastimes, the HPN patients spent less time out enjoying themselves (45% v 19%, p = 0.03) and socialised less (43% v 11%, p = 0.003). They also did less physical training and exercise than the non-HPN patients (41% v 17%, p = 0.03).
On the 9 cm visual analogue scale measuring the overall feeling of quality of life, the HPN patients had a lower score (median (25-75%) 4.9 (3.0-7.2) cm) than the non-HPN patients (median (25-75%) 6.8 (4.8-8.2) cm) (p = 0.008). Table 2 gives a comparison of the IBDQ scores between the HPN and non-HPN patients. The response options for each question were framed as a seven point scale on which 7 represented best function and 1 represented worst function. Not only regarding the overall scores, but also in areas of systemic symptoms and emotional and social function, the HPN patients scored worse (lower score) than the non-HPN patients. Significance was not reached for overall bowel symptoms (5.2 v 5.7, p = 0.08). Table 2 also gives responses to the individual questions in the IBDQ. The HPN patients reported more episodes of loose bowel movements and abdominal pain than the non-HPN patients, and they had more nausea and vomiting. Systemically the HPN patients felt more fatigue than the non-HPN patients, and they tended to score worse (lower score) with regard to energy for everyday activities. The HPN patients reported having more problems sleeping than the non-HPN patients. With regard to emotional functions, the HPN patients felt more anger as a result of their bowel problem than the non-HPN patients, and when asked how satisfied, happy, or pleased they were with their personal life, they scored worse (lower score) than the non-HPN patients. None of the diVerences in responses to individual questions on social function reached statistical significance, but an overall worse score (lower score) was seen in the HPN patients compared with non-HPN patients. No diVerences were seen between the two groups with regard to limitations in sexual activity. Some 55% of the HPN patients and 53% of the non-HPN patients, however, reported that their bowel problem had reduced their sexual activity.
IBDQ SCORES
EFFECT OF SEX AND AGE ON SIP AND IBDQ SCORES
To evaluate the eVect of sex and age on the SIP and IBDQ scores, the HPN patients were divided according to sex and age below and above 45 years. Eighteen patients were men and 31 women, and 23 patients were less than 45 and 26 were more than 45.
Sex
The median age in the male and female HPN population was 45.4 and 46.1 years respectively (p = 0.55). Figure 2A , B gives the SIP and IBDQ scores respectively arranged by sex. The female HPN patients scored significantly worse (higher score) overall and for the physical and psychosocial dimensions and the independent categories. An analysis of the physical dimension showed that the female HPN patients had worse SIP scores (higher score) with regard to both ambulation and mobility (22% v 10%, p = 0.002) and body care and movement (12% v 6%, p = 0.002) compared with the male HPN patients. In the psychosocial dimension no significant diVerence was seen between sexes with regard to social interaction, but the female patients scored worse (higher score) in areas of alertness and emotional behaviour (22% v 11%, p = 0.009) and communication (5% v 1%, p = 0.04) compared with the male HPN patients.
With respect to the individual categories, no differences were seen between the sexes with regard to sleep and rest, eating, work or recreation and pastimes. The female HPN patients, however, scored significantly worse (higher score) with regard to home management (30% v 16%, p<0.001). When considering the 9 cm visual analogue scale for overall feeling of quality of life, the female HPN patients tended to score worse (lower score: median (25-75%) 4.6 (2.2-7.0) cm) than the male HPN patients (6.6 (4.5-7.4) cm) (p = 0.068).
With regard to the IBDQ scores, the female HPN patients scored significantly worse (lower score) overall as well as in the systemic symptoms and emotional function categories. No diVerences could be shown for bowel symptoms and social function between the sexes ( fig  2B) . Analysis of the responses to the individual questions on bowel symptoms, however, showed that the female HPN patients scored worse (lower score) in the question on pain in the abdomen 
Age
The male/female ratio in the HPN patients below and above the age of 45 years was 8/17 Figure 2C , D gives a comparison of the SIP and IBDQ scores respectively between the younger and older HPN patients. The patients below the age of 45 years scored significantly better (lower score) on the overall SIP score and the physical and psychosocial dimensions, whereas no diVerences were encountered for the independent category. An analysis of the categories in the physical dimension showed that body care and movement were better (lower score) in the younger age group (SIP score 8% v 12%, p = 0.03), whereas the diVerences in responses to questions on ambulation and mobility did not reach statistical significance. In the psychosocial dimension, the SIP score was worse (higher score) with regard to alertness and emotional behaviour in the older HPN patients (23% v 12%, p = 0.005). No diVerences were encountered for social interaction and communication. In the independent categories no diVerences were detected with regard to sleep and rest, eating, and recreation and pastimes between younger and older HPN patients, but the younger HPN patients did better (lower score) with regard to work (SIP score 74% v 96%, p = 0.04) and home management (SIP score 17% v 32%, p<0.001) than the older patients.
Figure 2 Mean sickness impact profile (SIP) scores and median inflammatory bowel disease questionnaire (IBDQ) scores according to sex (A and B) and age (C and D) in the patients on home parenteral nutrition (HPN
When considering the 9 cm visual analogue scale for overall feeling of quality of life, no difference was seen between the younger and older HPN patients (median (25-75%) 6.3 (4.4-7.3) cm v 4.7 (2.2-7.1) cm, p = 0.17).
Concerning the IBDQ scores, the younger HPN patients did significantly better (higher score) than older HPN patients with regard to systemic symptoms and social function, whereas no diVerences were seen with regard to bowel symptoms and emotional function. The overall IBDQ score tended to be better (higher score) in the younger HPN patients but the diVerence did not reach statistical significance (p = 0.076). An analysis of the responses to individual questions on bowel symptoms and emotional function did not disclose any significant diVerences. In questions on systemic symptoms, the older patients scored worse (lower score) with regard to a feeling of energy (2.0 v 4.0, p = 0.03), whereas none of the differences in answers to the other questions reached statistical significance. Furthermore, none of the diVerences in responses to questions on social function reached statistical significance.
EFFECT OF THE PRESENCE OF A STOMA, DIAGNOSIS, AND DURATION OF HPN ON SIP AND IBDQ SCORES
Presence of a stoma
To evaluate the eVect of the presence of a stoma on quality of life scores, both the non-HPN and HPN patients were divided into those with a stoma and those without. Figure  3A , B gives a comparison of the SIP and IBDQ scores between the non-HPN patients with and without a stoma, and figure 3C , D gives the comparison between the HPN patients with and without a stoma. The median age did not diVer significantly between the non-HPN patients with and without a stoma (49 v 50 years, p = 0.95), the number of men did not diVer significantly (10 of 19 v 11 of 17), and most of the patients in both groups had inflammatory bowel disease (13 of 19 and 17 of 17) . None of the non-HPN patients suVered from intestinal dysmotility. In these non-HPN patients no significant diVerences were observed for the SIP and IBDQ scores in patients with and without a stoma. In the HPN patients the median age in the patients with a stoma was significantly higher than in those without (49 v 32 years, p<0.01) and the number of men tended to be higher (6 of 11 (55%) v 11 of 38 (29%)). Furthermore, most (28 of 38) HPN patients with a stoma suVered from inflammatory bowel disease whereas most HPN patients without a stoma suVered from intestinal dysmotility (6 of 11). In these HPN patients without a stoma, a significantly better (lower) overall SIP score was observed, as well as in the physical and psychosocial dimensions but not the independent categories, compared with HPN patients with a stoma. Concerning the IBDQ scores, the HPN patients without a stoma only scored better (lower score) on emotional function. The non-HPN patients with a stoma were subsequently compared with the HPN patients with a stoma to evaluate the eVect of HPN per se. The number of HPN and non-HPN patients without a stoma was too small for meaningful analysis. The faecal weight did not diVer significantly in the non-HPN patients with a stoma compared with the HPN patients with a stoma (1.59 v 2.25 kg/day, p = 0.21). The HPN patients with a stoma scored significantly worse (higher score, fig 3C) compared with the non-HPN patients with a stoma (fig 3A) with regard to the overall SIP score (18% v 7%, p<0.001), the physical (14% v 4%, p<0.001) and psychosocial (16% v 8%, p<0.001) dimensions, and the independent category (21% v 8%, p<0.001). Concerning the IBDQ scores, the HPN patients with a stoma did significantly worse (lower score, fig 3D) than the non-HPN patients with a stoma (fig 3B) with regard to the overall IBDQ score (4.9 v 5.8, p<0.01), the bowel (5.2 v 6.1, p<0.05) and systemic symptoms (3.7 v 5.4, p<0.01), and the emotional function (5.2 v 6.0, p<0.05). The score for social function tended to be worse (lower score) (3.9 v 4.8, p = 0.05).
Diagnosis
The HPN patients were divided into three groups according to diagnosis (fig 4A, B) : one group of 31 patients (11 men), median age 44.8 years, had inflammatory bowel disease; another group of eight patients (two men), median age 58.1 years, had had an intestinal resection because of mesenteric disease or complications during surgery; the third group of 10 patients (four men), median age 48.4 years, suVered from intestinal dysmotility. The three groups diVered significantly according to the overall SIP scores. The patients with intestinal resection due to mesenteric disease or complications during surgery had the worse scores (higher score) (23%), the patients with dysmotility did slightly better (19%), and the patients with inflammatory bowel disease had the best score (lower score) (15%). In general, this pattern was observed in the physical and psychosocial dimensions and in the independent categories. No significant diVerences were observed for the IBDQ scores in the three groups according to diagnosis. Figure 4C , D segregates the HPN patients according to duration of HPN. Eight patients (three men), median age 44.5 years, had received HPN for less than two years. Twenty The nine intestinal transplant recipients reported a significant disruption in most areas of their lives when comparing "before illness" with "during illness" (while on HPN). When comparing "post-transplant" with "during illness" (while on HPN), they experienced a significant improvement in most areas of quality of life and they reported that quality of life after the transplantation compared favourably with their state before the illness. The study may, however, be subject to bias, as results were probably only obtained from the patients who had had a successful transplantation.
Duration of HPN
Figure 4 Mean sickness impact profile (SIP) scores and median inflammatory bowel disease questionnaire (IBDQ) scores according to diagnosis (A and B) and duration of home parenteral nutrition (HPN) (C and D). IBD, patients with inflammatory bowel disease; MD+OP, patients with intestinal resection because of mesenteric vascular disease or complications of intra
Although the results of small bowel transplantation look increasingly promising, the well adjusted adult patients on HPN are being advised to continue with HPN. However, when the survival after small bowel transplantation improves, and when measurements of quality of life in these patients compare well with life on HPN in a larger series, recommendations may change.
The quality of life in Danish patients with Crohn's disease and their healthy "buddy controls" was recently studied using the IBDQ. 21 In the "buddy controls" the scores in the systemic, emotional, and social dimensions (median (25-75%)) were 5.8 (5.2-6.4), 6 .0 (5.7-6.5), and 7.0 (6.2-7.0) respectively. In the patients with Crohn's disease the scores were significantly reduced to 5. Results obtained using the non-disease specific SIP questionnaire may be compared with those for patients with other chronic diseases. Laupacis and colleagues 22 investigated the quality of life in a cohort of 168 patients with end stage renal disease treated by dialysis who were on a transplant waiting list. Mean age was 42 years, and 104 of the patients were men. The SIP scores for the total physical and psychosocial dimensions were 6.4% and 12.4% respectively compared with 13% and 14% in HPN patients in this study. The SIP scores for the independent categories sleep and rest, eating, work, home management, and recreation and pastimes were 24, 9, 40, 16, and 32% respectively compared with 21, 20, 86, 25, and 32% in HPN patients in this study. The overall SIP score was 13% in the patients with renal disease compared with 17% in HPN patients.
Thus the reduced quality of life compares with that reported in patients with chronic renal failure treated by dialysis.
Although HPN has evolved to be a successful, advanced, widespread, and lifesaving technique in the management of intestinal failure, the future quality control of medical care must also focus on the optimum rehabilitation of the HPN patient, not only with respect to physical function and survival, but also psychosocial and emotional function, aiming at the best possible overall quality of life in these patients.
